Manfred Dahm

Manfred Dahm

Auto-generated profile, based on publicly available information

Manfred Dahm

Department of Cardiothoracic and Vascular Surgery, Westpfalz Klinikum, 67655 Kaiserslautern, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
DPDiethard Pruefer
Diethard Pruefer
UBUte Buerke
Ute Buerke
MKMarkus Khalil
Markus Khalil
MDManfred Dahm
Manfred Dahm
HDHarald Darius
Harald Darius
MBMichael Buerke
Michael Buerke

1 January 2001 in Scandinavian Journal of Clinical and Laboratory Investigation
Verified
Journal Article
Closed access
GHG Hafner
G Hafner
DPD Peetz
D Peetz
HEH Erbes
H Erbes
FPF Post
F Post
MDM Dahm
M Dahm
WPW Prellwitz
W Prellwitz
An analytical and clinical evaluation of cardiac troponin I (cTnI) on the IMMULITE system is presented. The assay results were compared with those of the Stratus II and the Dimension RxL-HM. A between-run imprecision CV < 20% was found at a cTnI concentration of 0.23 microg/L (functional limit of detection). On the basis of a reference study including 215 patients without ischemic heart disease (97.5th percentile: 0.294 microg/L) and 36 patients clinically classified as having stable angina pectoris (<0.22 microg/L) a preliminary cutoff level of 0.3 microg/L was defined. Assay linearity, sample stability, influence of sample material and method comparison studies were performed. In patients with Duchenne's disease, chronic hemodialysis treatment, pulmonary embolism, coronary artery bypass surgery and minimally cardiac surgery the cTnI results of the IMMULITE agreed better with the Dimension RxL-HM than with the Stratus II data. Of 142 samples from patients with unstable angina 67 samples were classified as cTnI positive with the IMMULITE, 76 with the Dimension RxL-HM, and 62 with the Stratus II. In conclusion, the new assay is sensitive for the determination of cTnI and easy to perform within 45 min.

1 November 2004 in Bio-Medical Materials and Engineering
Verified
Journal Article
Closed access
MDManfred Dahm
Manfred Dahm
JRJürgen Rühe
Jürgen Rühe
BBBernd Berchthold
Bernd Berchthold
DPDiethard Prüfer
Diethard Prüfer
OPOswald Prucker
Oswald Prucker
HOHellmut Oelert
Hellmut Oelert
Reoperation of aldehyde tanned bioprotheses due to calcific degeneration remains their major drawback. Based on experiments studying mechanisms and factors that influence the time phase, extent and progression of calcification and evaluating the efficiency of anticalcification treatments and the effects of surface seeding with vital cells a new concept to avoid calcification emerged: masking aldehyde‐residues with a covalently bound polymer that supports surface cell seeding. Different covalently bound polymers were tested for their suitability to grow cells. Dense cell growth was achieved on some polymers but without correlation to physico‐chemical properties. Ultrathin coating of biological materials appears a promising approach to achieve lining with vital cells.

21 April 2026 in Exploration of Targeted Anti-tumor Therapy
Verified
Journal Article
Open access
PDF file
VLVasileios Leivaditis
Vasileios Leivaditis
KGKonstantinos Grapatsas
Konstantinos Grapatsas
Francesk MulitaFrancesk Mulita
Francesk Mulita
SMSofoklis Mitsos
Sofoklis Mitsos
Efstratios N KoletsisEfstratios N Koletsis
Efstratios N Koletsis
MDManfred Dahm
Manfred Dahm
Solitary fibrous tumors (SFTs) are rare mesenchymal neoplasms that typically arise from the pleura but may occur in various extrathoracic sites. Primary intraparenchymal pulmonary SFTs without pleural attachment are exceptionally uncommon and often pose diagnostic and therapeutic challenges. We report the case of a middle-aged female patient presenting with progressive dyspnea and a large mass in the left lower lobe on imaging. Computed tomography revealed a well-circumscribed, hypervascular mass occupying the left lower lobe. Bronchoscopic and percutaneous biopsies were nondiagnostic, and surgical resection was pursued. Intraoperatively, the tumor was found to arise from the lung parenchyma without pleural involvement. Histopathological examination demonstrated a spindle-cell neoplasm with the typical “patternless pattern,” and immunohistochemistry confirmed nuclear STAT6 positivity, establishing the diagnosis of SFT. The postoperative course was uneventful apart from a transient pulmonary embolism, which was successfully treated. The patient was discharged in good condition and is under regular radiologic surveillance. SFTs of the lung are rare and often mimic more common pulmonary tumors radiologically. Histologic confirmation with STAT6 immunohistochemistry is crucial for accurate diagnosis. Complete surgical excision remains the mainstay of treatment. Given the risk of late recurrence—especially in large tumors—long-term imaging follow-up is mandatory. This case highlights the importance of considering SFT in the differential diagnosis of large pulmonary masses, the critical role of STAT6-based histopathologic confirmation, and the necessity for prolonged surveillance even after complete resection.

1 January 2000
Verified
Book Chapter
Closed access
PDF file
APA. A. Peivandi
A. A. Peivandi
MDM. Dahm
M. Dahm
GHG. Hafner
G. Hafner
SGStefan Guth
Stefan Guth
ALA. H. Loos
A. H. Loos
HOH. Oelert
H. Oelert

1 January 2003
Verified
Book Chapter
Closed access
APA. A. P. Peivandi
A. A. P. Peivandi
MDM. Dahm
M. Dahm
EQE. Quinkenstein
E. Quinkenstein
ALA. H. Loos
A. H. Loos
HOH. Oelert
H. Oelert